6Degrees: The Israeli Wearable-AI Motion-Control Warrant in Our Newchip Portfolio

AdValorem Research | August 5, 2026

6Degrees is a Tel Aviv-based wearable-AI and motion-control company focused on assistive technology. In the Frontier Alternatives research framework, it is profiled as the warrant we hold via the Newchip portfolio in the Frontier Alternatives Fund. The relevant question is not whether a small device can produce an impressive demonstration; it is whether a personalized motion interface can become dependable, affordable, and useful across the many settings where people with limited hand mobility need to interact with digital tools.

This is a company profile focused on product, market context, and research signals. The company’s own description positions its MyMove system as a way to convert human motion into digital commands, giving users a hands-free path to control phones, computers, tablets, and other smart devices. 6Degrees’ product overview describes a wearable system that learns a user’s movement, filters motion through self-stabilization, and supports gestures such as swiping and selecting.

From wearable motion to digital command

The product proposition starts with a practical accessibility gap: touchscreens and computer mice assume a level of finger, wrist, or fine-motor control that many people do not have consistently. 6Degrees’ approach is to translate a user’s available movement into commands rather than asking the user to reproduce a standard gesture. That distinction matters. A device built around a person’s range of motion can potentially make everyday digital activity more accessible without requiring a new operating system or a specialized software environment.

The company describes the system as operating-system agnostic, with a Bluetooth connection and a rechargeable battery. It also highlights zero setup and personalization. Those details are commercially important because assistive products often face a usability test before they face a market-size test: if installation, calibration, or daily charging becomes burdensome, adoption can stall even when the underlying technology works. The company’s public materials also point to use cases including communication, work, family connection, and monitoring movement progress.

Why the assistive-tech lens matters

Assistive technology is increasingly evaluated at the intersection of consumer electronics, healthcare, and accessibility. That creates a broader opportunity set than a conventional wearable category, but it also raises the standard for evidence. A product may need to show that it works across different abilities, remains comfortable during extended use, and delivers a clear improvement over existing accessibility tools. It may also need to navigate the expectations associated with FDA and EU medical-device frameworks, depending on how its intended-use statements, distribution model, and product classification develop.

For research purposes, the important signal is the company’s attempt to make motion input adaptive rather than prescriptive. People with tremors or limited range of motion do not form a single user group, so the ability to learn and stabilize an individual’s movement is central to the thesis. The product’s potential value therefore rests less on novelty alone and more on repeatability: can the system recognize a user’s intent on an ordinary day, in an ordinary environment, with minimal friction?

Research-catalog signal: Sale 1, score 50

Within the AdValorem warrant research catalog, 6Degrees appears in the Sale 1 tranche with a score of 50. The score is a research-catalog marker, not a forecast or an independent valuation. It gives the team a consistent way to record the company alongside other early-stage technology profiles while keeping the analysis anchored to observable product, market, and execution questions. The relevant catalog reference is the AdValorem Warrant Research entry.

The queue provides no public investor names for 6Degrees, so this article does not infer an investor cap table from private-market references. That absence is itself a boundary for the analysis: the profile should be read through the product and the category rather than through an assumed list of backers. For a company at this stage, user evidence, device reliability, channel access, and the clarity of its regulatory path can be more informative than an incomplete investor narrative.

What the research process should watch next

• Recognition across user profiles. The core technical question is whether the system can maintain accurate command recognition for people with different movement patterns, limited range of motion, or tremors.
• Daily-use reliability. Battery life, Bluetooth stability, comfort, calibration time, and performance in real homes and workplaces will determine whether the product becomes a habit rather than a demonstration.
• Accessibility outcomes. The strongest evidence would show measurable gains in independence, communication, or productivity, while also documenting where the product complements existing accessibility features.
• Market pathway. The company’s positioning will clarify whether it is primarily a consumer device, an assistive-tech product distributed through care networks, or a hybrid. That choice affects pricing, support, reimbursement conversations, and the evidence customers expect.
• Regulatory and ecosystem fit. As the product’s intended-use statements and use cases mature, the company’s approach to FDA and EU medical-device expectations, privacy, and clinical or user validation will become important indicators of execution.

Research-positioning takeaway

6Degrees is a focused example of how wearable AI can extend beyond activity tracking into hands-free digital access. Its Tel Aviv base, assistive-technology orientation, MyMove motion interface, and Sale 1 research-catalog score of 50 place it in a category where product usefulness must be demonstrated through consistent everyday outcomes. For AdValorem Research, the appropriate stance is disciplined observation: track the company’s product validation, user adoption, market pathway, and framework readiness, and update the profile as evidence develops.